Toggle light / dark theme

The rise of AI (Artificial Intelligence) robots can be concerning for some people but that’s not stopping them for sure. In fact, there’s a chance that the AI robots will soon have ‘children’ with their owners. Yes, human-robot babies are very much possible, according to a leading artificial intelligence expert.

Dr David Levy, who is the author of Love and Sex with Robots claims that that humans and robots will soon make babies, given the ‘recent progress in stem cell research and artificial chromosomes.’

Though Dr Levy has not given a specific timeline for robot babies, he believes that it could happen within the next 100 years.

Read more

Biotech is one of today’s many hot frontiers of technology, but one thing holding it back is that it’s significantly less amenable to traditional computing techniques than other areas. A new startup called Asimov, spun off from research at MIT, is working on bridging the gap between the digital and the biological by creating, essentially, a set of computer-aided biology design tools. It’s a prescient enough idea that it has attracted $4.7 million in seed funding.

The problem that Asimov addresses is this. Say you’re a pharmaceutical company trying to make a tiny biocompatible machine that holds a certain amount of medication and releases it when it senses some other molecule.

In order to do so, you’d have to — well, among about a million other things — design what amounts to a logic gate and signal processor that works at the molecular scale. This is a daunting prospect, as creating molecular machinery is a labor-intensive process often involving creating thousands of variations of a given structure and testing them repeatedly to see which works.

Read more

In a historic move, the Food and Drug Administration on Tuesday approved a pioneering gene therapy for a rare form of childhood blindness, the first such treatment cleared in the United States for an inherited disease.

The approval signals a new era for gene therapy, a field that struggled for decades to overcome devastating setbacks but now is pushing forward in an effort to develop treatments for haemophilia, sickle-cell anaemia, and an array of other genetic diseases.

Yet the products, should they reach patients, are likely to carry stratospheric prices – a prospect already worrying consumer advocates and economists.

Read more

2018 announces Program and Speakers!

This conference is focused on the cellular and molecular repair of age-related damage as the basis of therapies to bring aging under full medical control, It will mirror the structure of SENS, with sessions devoted to each strand and to the enabling technologies that multiple strands will rely upon. Sessions will cover a wide range of topics across the damage-repair spectrum.

Further details are given below:


Accelerating rejuvenation therapies to repair the damage of aging. Berlin, March, 15 — 17.

Read more

The 2017 Project for Awesome (P4A) has ended, and what a weekend it has been! We have had a significant number of videos created in support of our work, and the encouragement from the community has been superb. It is very inspiring to hear what people have to say about the importance of our work and why they appreciate the work we do. Today, we wanted to have a look at some of the great videos created by the LEAF team and our awesome community.

LEAF President Keith Comito led the charge during P4A and talks about our motivations and our vision for a world without age-related diseases. Science is making huge leaps in progress, and we no longer have to accept age-related diseases as inevitable.

Read more

NEW YORK (Reuters) — The early hope that stem cell therapy would make the paralyzed walk, the blind see and cure diabetes have given way to a long list of failures, highlighted by early stem cell champion Geron Corp abandoning the field in 2011.

But two small companies, Athersys Inc and Mesoblast Ltd, are beginning final stage trials in hundreds of patients that they — along with loyal investors — say could change the course of devastating stroke and heart failure.

Both have overcome major hurdles to manufacturing stem cell treatments on a large scale that are off-the-shelf products derived from healthy donor bone marrow and do not face immune system rejection issues.

Read more

The topic of healthspan is increasingly being raised in the popular media, but what does it really mean? Simply put, healthspan means the period of your life in which you remain healthy and free from age-related diseases. The Roman poet Virgil once said “The greatest wealth is health”, so the concept of healthspan was something valued as far back in time as then.

Today, we are going to take a look at how we have been trying to increase human healthspan in the past and what science is doing now to take us to new frontiers of health through a new approach to medicine called rejuvenation biotechnology.

So, why is healthspan becoming such a popular saying, and why is it appearing frequently in articles and in other media now? Quite simply, the advances in our understanding of the aging processes and our ability to do something about them has reached the point at which taking measures to increase healthspan is now plausible.

Read more

The genetic atlas revealed new information about health risks, ancient political borders, and the influence of Vikings.

Learn how your family history is connected to the human journey with National Geographic’s Geno 2.0 DNA ancestry kit.

A new “DNA atlas” of Ireland is revealing some of the surprising ways historic kingdoms have influenced populations on the island—and it offers the first genetic evidence that Vikings intermingled with ancient Irish peoples.

Read more